View in EDS

Timing-dependent skin toxicity phenotypes during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinoma.

Saved in:
Bibliographic Details
Title: Timing-dependent skin toxicity phenotypes during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinoma.
Authors: Hashimoto M; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan., Inoki L; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan., Yamamoto Y; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan., Fukuokaya W; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Yanagisawa T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Mori K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Maenosono R; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Yoshikawa Y; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Tsujino T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Saruta M; Department of Urology, Fujita Health University School of Medicine, Aichi, Japan., Nukaya T; Department of Urology, Fujita Health University School of Medicine, Aichi, Japan., Oishi Y; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan., Tamura K; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan., Sugiyama S; Department of Urology, Kawasaki Medical School, Okayama, Japan., Morinaka H; Department of Urology, Kawasaki Medical School, Okayama, Japan., Komura K; Department of Urology, Kawasaki Medical School, Okayama, Japan., Takahara K; Department of Urology, Fujita Health University School of Medicine, Aichi, Japan., Inamoto T; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan., Fujita K; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan. kfujita@med.kindai.ac.jp.; Department of Urology, Kindai University Hospital, 1-14-1 Miharadai, Minami-ku, Sakai, Osaka, 590-0197, Japan. kfujita@med.kindai.ac.jp.
Corporate Authors: ULTRA-J group
Source: International journal of clinical oncology [Int J Clin Oncol] 2026 Jul 27. Date of Electronic Publication: 2026 Jul 27.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42509450
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Timing-dependent skin toxicity phenotypes during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hashimoto+M%22">Hashimoto M</searchLink>; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Inoki+L%22">Inoki L</searchLink>; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Yamamoto+Y%22">Yamamoto Y</searchLink>; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Fukuokaya+W%22">Fukuokaya W</searchLink>; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yanagisawa+T%22">Yanagisawa T</searchLink>; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Mori+K%22">Mori K</searchLink>; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Maenosono+R%22">Maenosono R</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshikawa+Y%22">Yoshikawa Y</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Tsujino+T%22">Tsujino T</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Saruta+M%22">Saruta M</searchLink>; Department of Urology, Fujita Health University School of Medicine, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Nukaya+T%22">Nukaya T</searchLink>; Department of Urology, Fujita Health University School of Medicine, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Oishi+Y%22">Oishi Y</searchLink>; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.<br /><searchLink fieldCode="AU" term="%22Tamura+K%22">Tamura K</searchLink>; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.<br /><searchLink fieldCode="AU" term="%22Sugiyama+S%22">Sugiyama S</searchLink>; Department of Urology, Kawasaki Medical School, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Morinaka+H%22">Morinaka H</searchLink>; Department of Urology, Kawasaki Medical School, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Komura+K%22">Komura K</searchLink>; Department of Urology, Kawasaki Medical School, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Takahara+K%22">Takahara K</searchLink>; Department of Urology, Fujita Health University School of Medicine, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Inamoto+T%22">Inamoto T</searchLink>; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.<br /><searchLink fieldCode="AU" term="%22Fujita+K%22">Fujita K</searchLink>; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan. kfujita@med.kindai.ac.jp.; Department of Urology, Kindai University Hospital, 1-14-1 Miharadai, Minami-ku, Sakai, Osaka, 590-0197, Japan. kfujita@med.kindai.ac.jp.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ULTRA-J+group%22">ULTRA-J group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229616295%22">International journal of clinical oncology</searchLink> [Int J Clin Oncol] 2026 Jul 27. <i>Date of Electronic Publication: </i>2026 Jul 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+Tokyo%22">Springer-Verlag Tokyo </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>9616295 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1437-7772 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213419625%22">13419625 </searchLink><i>NLM ISO Abbreviation: </i>Int J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42509450
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10147-026-03148-2
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Timing-dependent skin toxicity phenotypes during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hashimoto M
      – PersonEntity:
          Name:
            NameFull: Inoki L
      – PersonEntity:
          Name:
            NameFull: Yamamoto Y
      – PersonEntity:
          Name:
            NameFull: Fukuokaya W
      – PersonEntity:
          Name:
            NameFull: Yanagisawa T
      – PersonEntity:
          Name:
            NameFull: Mori K
      – PersonEntity:
          Name:
            NameFull: Maenosono R
      – PersonEntity:
          Name:
            NameFull: Yoshikawa Y
      – PersonEntity:
          Name:
            NameFull: Tsujino T
      – PersonEntity:
          Name:
            NameFull: Saruta M
      – PersonEntity:
          Name:
            NameFull: Nukaya T
      – PersonEntity:
          Name:
            NameFull: Oishi Y
      – PersonEntity:
          Name:
            NameFull: Tamura K
      – PersonEntity:
          Name:
            NameFull: Sugiyama S
      – PersonEntity:
          Name:
            NameFull: Morinaka H
      – PersonEntity:
          Name:
            NameFull: Komura K
      – PersonEntity:
          Name:
            NameFull: Takahara K
      – PersonEntity:
          Name:
            NameFull: Inamoto T
      – PersonEntity:
          Name:
            NameFull: Fujita K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 07
              Text: 2026 Jul 27
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1437-7772
          Titles:
            – TitleFull: International journal of clinical oncology
              Type: main
ResultId 1